Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEUPROLIDE vs LEVODOPA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEUPROLIDE vs LEVODOPA: Safety Overview

Metric LEUPROLIDE LEVODOPA
Total FAERS Reports 70,893 6,610
Deaths Reported 11,858 546
Death Rate 16.7% 8.3%
Hospitalizations 10,499 729
Average Patient Age 67.5 yrs 69.3 yrs
% Female Patients 14.1% 42.9%
FDA Approval Date Apr 14, 2023 Approved Prior to Jan 1, 1982
Manufacturer TOLMAR Inc. Deseret Biologicals, Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Discontinued Discontinued